Found: 166
Select item for more details and to access through your institution.
Implementation of guideline‐directed medical therapy for heart failure: Progress achieved, work ahead!
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 10, p. 2258, doi. 10.1002/ejhf.3438
- By:
- Publication type:
- Article
Risk stratification in patients presenting with acute heart failure.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, v. 10, n. 2, p. 113, doi. 10.1093/ehjacc/zuab005
- By:
- Publication type:
- Article
Risk stratification in patients presenting with acute heart failure.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
- By:
- Publication type:
- Article
Loop diuretic therapy with or without heart failure: impact on prognosis.
- Published in:
- European Heart Journal, 2024, v. 45, n. 37, p. 3837, doi. 10.1093/eurheartj/ehae345
- By:
- Publication type:
- Article
A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
- Published in:
- European Heart Journal, 2024, v. 45, n. 16, p. 1430, doi. 10.1093/eurheartj/ehad888
- By:
- Publication type:
- Article
A 20-year population study of peripartum cardiomyopathy.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5128, doi. 10.1093/eurheartj/ehad626
- By:
- Publication type:
- Article
Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials.
- Published in:
- European Heart Journal, 2023, v. 44, n. 37, p. 3658, doi. 10.1093/eurheartj/ehad346
- By:
- Publication type:
- Article
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2930, doi. 10.1093/eurheartj/ehad283
- By:
- Publication type:
- Article
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2966, doi. 10.1093/eurheartj/ehad341
- By:
- Publication type:
- Article
Stroke in patients with heart failure and reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2998, doi. 10.1093/eurheartj/ehad338
- By:
- Publication type:
- Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2202, doi. 10.1093/eurheartj/ehad210
- By:
- Publication type:
- Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2170, doi. 10.1093/eurheartj/ehad276
- By:
- Publication type:
- Article
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1136, doi. 10.1093/eurheartj/ehad083
- By:
- Publication type:
- Article
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 8, p. 668, doi. 10.1093/eurheartj/ehac801
- By:
- Publication type:
- Article
A welcome 'failure' of gliflozins: blood pressure reduction in heart failure.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 408, doi. 10.1093/eurheartj/ehac712
- By:
- Publication type:
- Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 42, p. 4469, doi. 10.1093/eurheartj/ehac487
- By:
- Publication type:
- Article
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4406, doi. 10.1093/eurheartj/ehac481
- By:
- Publication type:
- Article
Bringing FIDELITY to the estimate of treatment effects of finerenone in chronic kidney disease due to type 2 diabetes.
- Published in:
- European Heart Journal, 2022, v. 43, n. 6, p. 485, doi. 10.1093/eurheartj/ehab827
- By:
- Publication type:
- Article
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
- Published in:
- European Heart Journal, 2021, v. 42, n. 36, p. 3727, doi. 10.1093/eurheartj/ehab560
- By:
- Publication type:
- Article
Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
- Published in:
- European Heart Journal, 2021, v. 42, n. 36, p. 3741, doi. 10.1093/eurheartj/ehab499
- By:
- Publication type:
- Article
Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1199, doi. 10.1093/eurheartj/ehz916
- By:
- Publication type:
- Article
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy.
- Published in:
- European Heart Journal, 2020, v. 41, n. 25, p. 2379, doi. 10.1093/eurheartj/ehaa183
- By:
- Publication type:
- Article
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction.
- Published in:
- European Heart Journal, 2020, v. 41, n. 25, p. 2356, doi. 10.1093/eurheartj/ehaa184
- By:
- Publication type:
- Article
Association is not causation: treatment effects cannot be estimated from observational data in heart failure.
- Published in:
- European Heart Journal, 2018, v. 39, n. 37, p. 3417, doi. 10.1093/eurheartj/ehy407
- By:
- Publication type:
- Article
Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005.
- Published in:
- BMC Neurology, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12883-014-0257-1
- By:
- Publication type:
- Article
Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005.
- Published in:
- BMC Neurology, 2015, v. 15, n. 1, p. 26, doi. 10.1186/s12883-014-0257-1
- By:
- Publication type:
- Article
Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986-2005: a retrospective cohort study.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 24, p. 2094, doi. 10.1001/jama.2024.6774
- By:
- Publication type:
- Article
Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0255364
- By:
- Publication type:
- Article
Prior psychiatric hospitalization is associated with excess mortality in patients hospitalized with non-cardiac chest pain: a data linkage study based on the full Scottish population (1991–2006).
- Published in:
- European Heart Journal, 2012, v. 33, n. 6, p. 760, doi. 10.1093/eurheartj/ehr401
- By:
- Publication type:
- Article
Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.
- Published in:
- European Heart Journal, 2012, v. 33, n. 3, p. 314, doi. 10.1093/eurheartj/ehr433
- By:
- Publication type:
- Article
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1788, doi. 10.1002/ejhf.3352
- By:
- Publication type:
- Article
Use of medical therapy and risk of clinical events according to frailty in heart failure patients – A real‐life cohort study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1717, doi. 10.1002/ejhf.3249
- By:
- Publication type:
- Article
Dapagliflozin and quality of life measured using the EuroQol 5‐dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1524, doi. 10.1002/ejhf.3263
- By:
- Publication type:
- Article
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1334, doi. 10.1002/ejhf.3266
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 912, doi. 10.1002/ejhf.3184
- By:
- Publication type:
- Article
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 245, doi. 10.1002/ejhf.3114
- By:
- Publication type:
- Article
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 107, doi. 10.1002/ejhf.3085
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2177, doi. 10.1002/ejhf.3043
- By:
- Publication type:
- Article
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE‐HF model.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 1962, doi. 10.1002/ejhf.3028
- By:
- Publication type:
- Article
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 2078, doi. 10.1002/ejhf.3000
- By:
- Publication type:
- Article
Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1831, doi. 10.1002/ejhf.2944
- By:
- Publication type:
- Article
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1606, doi. 10.1002/ejhf.2962
- By:
- Publication type:
- Article
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1213, doi. 10.1002/ejhf.2965
- By:
- Publication type:
- Article
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1364, doi. 10.1002/ejhf.2912
- By:
- Publication type:
- Article